학술논문
Diminished seroconversion following a single SARS-COV-2 vaccine in ocrelizumab-treated relapsing-remitting multiple sclerosis patients
Document Type
Article
Source
In: Multiple Sclerosis Journal . (Multiple Sclerosis Journal, June 2022, 28(7):1126-1130)
Subject
Language
English
ISSN
14770970
13524585
13524585